AI is about to change healthcare. These 6 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Mainstreet Equity, you really have to believe in the underlying rental platform more than the headline earnings, because the latest numbers complicate the story. The third quarter showed revenue still edging higher, but net income and EPS dropped sharply for both the quarter and the nine‑month period, reinforcing the existing concern around margin compression and the quality of past earnings, which included large one‑off gains. In the short term, that weak profitability blunts catalysts tied to buybacks and the rising dividend, since both now sit against thinner earnings cover and interest costs that are not well cushioned by current profits. The ongoing issuer bid and a share price below analyst targets still matter, but after this result the key question is whether earnings can better support Mainstreet’s capital allocation choices.
However, one risk investors should be aware of is how weaker earnings interact with rising capital returns. Despite retreating, Mainstreet Equity's shares might still be trading 8% above their fair value. Discover the potential downside here.Explore 3 other fair value estimates on Mainstreet Equity - why the stock might be worth 32% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com